VCWA
ABBV icon

Vanguard Capital Wealth Advisors’s AbbVie ABBV Stock Holding History

Vanguard Capital Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$971K Buy
3,858
+167
+5% +$35.9K 0.66% 32
2026
Q1 		$803K Sell
3,691
-156
-4% -$34.6K 0.74% 32
2025
Q4 		$879K Sell
3,847
-281
-7% -$64K 0.7% 32
2025
Q3 		$956K Sell
4,128
-11
-0.3% -$2.24K 0.76% 34
2025
Q2 		$768K Buy
4,139
+449
+12% +$83.4K 0.76% 30
2025
Q1 		$773K Hold
3,690
– – 0.95% 24
2024
Q4 		$656K Sell
3,690
-23
-0.6% -$4.23K 0.71% 29
2024
Q3 		$733K Sell
3,713
-638
-15% -$119K 0.77% 28
2024
Q2 		$746K Sell
4,351
-64
-1% -$10.6K 0.5% 40
2024
Q1 		$804K Buy
4,415
+6
+0.1% +$1.03K 0.57% 39
2023
Q4 		$683K Buy
4,409
+89
+2% +$13K 0.55% 36
2023
Q3 		$644K Sell
4,320
-118
-3% -$17.3K 0.6% 40
2023
Q2 		$598K Sell
4,438
-194
-4% -$28.4K 0.54% 41
2023
Q1 		$738K Sell
4,632
-101
-2% -$15.4K 0.74% 33
2022
Q4 		$765K Sell
4,733
-27
-0.6% -$4.14K 0.89% 27
2022
Q3 		$639K Sell
4,760
-197
-4% -$28.3K 0.78% 32
2022
Q2 		$759K Sell
4,957
-1,580
-24% -$241K 0.86% 27
2022
Q1 		$1.06M Buy
6,537
+1,605
+33% +$233K 0.76% 34
2021
Q4 		$667K Buy
4,932
+54
+1% +$6.38K 0.48% 53
2021
Q3 		$526 Sell
4,878
-545
-10% -$62.3K 0.35% 69
2021
Q2 		$610K Buy
5,423
+190
+4% +$21.4K 0.46% 58
2021
Q1 		$551K Sell
5,233
-117
-2% -$12.5K 0.47% 52
2020
Q4 		$563K Buy
+5,350
New +$514K 0.52% 51
2020
Q2 		$489K Buy
+4,986
New +$439K 0.57% 46
2019
Q4 		$366K Sell
4,135
-1,040
-20% -$86.3K 0.38% 78
2019
Q3 		$391K Buy
+5,175
New +$355K 0.46% 66

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Vanguard Capital Wealth Advisors's ABBV Position: Q2 2026 in Review

Vanguard Capital Wealth Advisors increased its AbbVie (ABBV) stake by 4.5% in Q2 2026, buying an estimated $35.9K and bringing the position to 3,858 shares worth $971K. The position accounts for 0.66% of the portfolio, ranked #32.

Vanguard Capital Wealth Advisors first reported a position in ABBV in Q3 2019 and has held it in 26 quarters since. The position peaked at $1.06M in Q1 2022. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vanguard Capital Wealth Advisors held 3,858 shares of AbbVie worth $971K as of Q2 2026.
  • Vanguard Capital Wealth Advisors bought 167 AbbVie shares in Q2 2026, an estimated $35.9K.
  • AbbVie made up 0.66% of Vanguard Capital Wealth Advisors's portfolio in Q2 2026, its #32 holding.
  • Vanguard Capital Wealth Advisors first reported a position in AbbVie in Q3 2019 and has held it in 26 quarters since.
  • Vanguard Capital Wealth Advisors's AbbVie position peaked at $1.06M in Q1 2022.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.